Clinical utility of serological markers in inflammatory bowel disease

Hepato-Gastroenterology

Volumn 56, Issue 89, 2009, Pages 162-166

  Mokrowiecka, Anna ^a   Daniel, Piotr ^a   Słomka, Marta ^a   Majak, Paweł ^b   Malecka Panas, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b N Copernicus Hospital   (Poland)

Author keywords

ASCA; Crohn's disease; Indeterminate colitis; Inflammatory bowel disease; PANCA; Serological markers; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER; FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLAMMATORY BOWEL DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; ROC CURVE; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

EID: 64949170304     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sands BE: From symptom to diagnosis: clinical distinction among various forms of intestinal inflammation. Gastroenterol 2004; 126:1518-1532.
2. Abreu MT, Vasiliauskas EA, Kam LY, Dubinsky MC: Use of serologic tests in Crohn's disease. Clinical Perspectives in Gastroenterology 2001; pg. 155-164.
3. Warren BF: Classic pathology of ulcerative colitis and Crohn's disease. J Clin Gastroenterol 2004; 38:S33-S35.
4. Robert ME, Skacel M, Ullman T: Patterns of colonic involvement at initial presentation in ulcerative colitis: a retrospective study of 46 newly diagnosed cases. Am J Clin Pathol 2004; 122:94-99.
5. Odze RD: Pathology of indeterminate colitis. J Clin Gastro-enterol; 2004; 38:S36-S40.
6. Geboes K, De Hertogh G: Indeterminate colitis. Inflammatory bowel diseases 2003; 9(5):324-331.
7. Vermeire S, Peeters M, Rutgeerts P: Diagnostic approach to IBD. Hepato-gastroenterology 2000; 47:44-48.
8. Shanahan F: Inflammatory bowel disease: immunodiagnostics, immunotherapeutics and ecotherapeutics. Gastro-enterol 2001; 120:622-635.
9. Plevy S: Do serological markers and cytokines determine the Indeterminate? J Clin Gastroenterol 2004; 38:S51-S56.
10. Koutroubakis IE, Petinaki E, Mouzas IA: Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in greek patients with IBD. AJG 2001; 96:449-454.
11. Oudkerk Pool M, Ellerbroek PM, Ridwan BU: Serum ANCA in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between pANCA and clinical parameters, medical and surgical treatment. Gut 1993; 34:46-50.
12. Sendid B, Quinton JF, Charrier G: Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 1998; 93:1306-1310.
13. Quinton JF, Sendid B, Reumaux D: Anti-Sachcaromyces cerevisiae mannan antibodies combined with ANCA in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42:788-791.
14. Joossens S, Reinisch W, Vermeire S: The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterol 2002; 122:1242-1247.
15. Silverberg M, Satsangi J, Ahmad T: Toward an integrated clinical, molecular and serological classification of IBD: Report of the Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19:5A-15A.
16. Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 24:2-6.
17. Peeters M, Joossens S, Vermeire S: Diagnostic value of anti-Sachcaromyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. AJG 2001; 96,3:730-734.
18. Austin GL, Shaheen NJ, Sandler RS: Positive and negative predictive value: use of inflammatory bowel disease serologic markers. AJG 2006; 101:413-416.
19. Dubinsky MC, Ofman JJ, Urman M: Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001; 96:758-765.
20. Hildebrand H: Chronic inflammatory bowel disease in children and adolescents in Sweden. J Pediatr Gastroenterol Nutr 1991; 13:293-297.
21. Stewenius J, Adnerhill I, Ekelund GR: Operations in unselected patients with ulcerative colitis and indeterminate colitis. Eur J Surg 1996; 162:131-137.
22. Kornbluth A, Sachar D: Ulcerative colitis Practice Guidelines in Adults (Update): ACG, Practice Parameters Committee. Am J Gastroenterol 2004; pg. 1371-1385.